HEADER HYDRO-LYASE 05-OCT-83 2CAB TITLE STRUCTURE, REFINEMENT AND FUNCTION OF CARBONIC ANHYDRASE ISOZYMES. TITLE 2 REFINEMENT OF HUMAN CARBONIC ANHYDRASE I COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBONIC ANHYDRASE FORM B; COMPND 3 CHAIN: A; COMPND 4 EC: 4.2.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS HYDRO-LYASE EXPDTA X-RAY DIFFRACTION AUTHOR K.K.KANNAN,M.RAMANADHAM,T.A.JONES REVDAT 7 14-FEB-24 2CAB 1 REMARK SEQADV LINK REVDAT 6 29-NOV-17 2CAB 1 HELIX REVDAT 5 24-FEB-09 2CAB 1 VERSN REVDAT 4 01-APR-03 2CAB 1 JRNL REVDAT 3 17-JUL-84 2CAB 1 REMARK REVDAT 2 30-MAY-84 2CAB 3 REMARK FTNOTE ATOM REVDAT 1 02-FEB-84 2CAB 0 SPRSDE 02-FEB-84 2CAB 1CAB JRNL AUTH K.K.KANNAN,M.RAMANADHAM,T.A.JONES JRNL TITL STRUCTURE, REFINEMENT, AND FUNCTION OF CARBONIC ANHYDRASE JRNL TITL 2 ISOZYMES: REFINEMENT OF HUMAN CARBONIC ANHYDRASE I JRNL REF ANN.N.Y.ACAD.SCI. V. 429 49 1984 JRNL REFN ISSN 0077-8923 JRNL PMID 6430186 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.K.KANNAN REMARK 1 TITL STRUCTURE AND FUNCTION OF CARBONIC ANHYDRASES REMARK 1 EDIT R.SRINIVASAN REMARK 1 REF BIOMOLECULAR STRUCTURE, V. 1 165 1980 REMARK 1 REF 2 CONFORMATION, FUNCTION AND REMARK 1 REF 3 EVOLUTION REMARK 1 PUBL PERGAMON PRESS, NEW YORK REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH K.K.KANNAN REMARK 1 TITL CRYSTAL STRUCTURE OF CARBONIC ANHYDRASE REMARK 1 EDIT C.BAUER, G.GROS, H.BARTELS REMARK 1 REF BIOPHYSICS AND PHYSIOLOGY OF 184 1980 REMARK 1 REF 2 CARBON DIOXIDE REMARK 1 PUBL SPRINGER VERLAG, BERLIN REMARK 1 REFN REMARK 1 REFERENCE 3 REMARK 1 AUTH K.K.KANNAN,M.RAMANADHAM REMARK 1 TITL STRUCTURE, REFINEMENT, AND FUNCTION OF HUMAN CARBONIC REMARK 1 TITL 2 ANHYDRASE-B REMARK 1 REF INT.J.QUANTUM CHEM.QUANTUM V. 20 199 1981 REMARK 1 REF 2 CHEM.SYMP. REMARK 1 REFN ISSN 0161-3642 REMARK 1 REFERENCE 4 REMARK 1 AUTH K.K.KANNAN,M.PETEF,K.FRIDBORG,H.CID-DRESDNER,S.LOVGREN REMARK 1 TITL STRUCTURE AND FUNCTION OF CARBONIC ANHYDRASES. IMIDAZOLE REMARK 1 TITL 2 BINDING TO HUMAN CARBONIC ANHYDRACE B AND THE MECHANISM OF REMARK 1 TITL 3 ACTION OF CARBONIC ANHYDRASES REMARK 1 REF FEBS LETT. V. 73 115 1977 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 5 REMARK 1 AUTH K.K.KANNAN,B.NOTSTRAND,K.FRIDBORG,S.LOVGREN,A.OHLSSON, REMARK 1 AUTH 2 M.PETEF REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN ERYTHROCYTE CARBONIC ANHYDRASE B, REMARK 1 TITL 2 THREE-DIMENSIONAL STRUCTURE AT A NOMINAL 2.2 ANGSTROMS REMARK 1 TITL 3 RESOLUTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 72 51 1975 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 6 REMARK 1 AUTH B.NOTSTRAND,I.VAARA,K.K.KANNAN REMARK 1 TITL STRUCTURAL RELATIONSHIP OF HUMAN ERYTHROCYTE CARBONIC REMARK 1 TITL 2 ANHYDRASE ISOZYMES B AND C REMARK 1 EDIT C.L.MARKERT REMARK 1 REF ISOZYMES-MOLECULAR STRUCTURE V. 1 575 1975 REMARK 1 PUBL ACADEMIC PRESS,NEW YORK REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CORELS REMARK 3 AUTHORS : SUSSMAN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2009 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HELICES E1 AND E2 WERE ASSIGNED DEFAULT REMARK 3 TYPE 1 (ALPHA). REMARK 4 REMARK 4 2CAB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000177886. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.75000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 18.55000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 18.55000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.75000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 SER A 2 REMARK 465 PRO A 3 REMARK 465 ASP A 4 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 261 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 94 NE2 REMARK 620 2 HIS A 96 NE2 107.9 REMARK 620 3 HIS A 119 ND1 115.4 97.9 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 261 REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE 74 IN THIS ENTRY IS IDENTIFIED AS GLN. HOWEVER, REMARK 999 CHEMICAL SEQUENCE AND RECENT DIFFRACTION STUDIES ON AN REMARK 999 INHIBITOR COMPLEX INDICATE THAT IT SHOULD BE ASP. DBREF 2CAB A 1 260 UNP P00915 CAH1_HUMAN 1 260 SEQADV 2CAB GLN A 74 UNP P00915 ASP 74 CONFLICT SEQADV 2CAB ASP A 75 UNP P00915 ASN 75 CONFLICT SEQRES 1 A 260 ALA SER PRO ASP TRP GLY TYR ASP ASP LYS ASN GLY PRO SEQRES 2 A 260 GLU GLN TRP SER LYS LEU TYR PRO ILE ALA ASN GLY ASN SEQRES 3 A 260 ASN GLN SER PRO VAL ASP ILE LYS THR SER GLU THR LYS SEQRES 4 A 260 HIS ASP THR SER LEU LYS PRO ILE SER VAL SER TYR ASN SEQRES 5 A 260 PRO ALA THR ALA LYS GLU ILE ILE ASN VAL GLY HIS SER SEQRES 6 A 260 PHE HIS VAL ASN PHE GLU ASP ASN GLN ASP ARG SER VAL SEQRES 7 A 260 LEU LYS GLY GLY PRO PHE SER ASP SER TYR ARG LEU PHE SEQRES 8 A 260 GLN PHE HIS PHE HIS TRP GLY SER THR ASN GLU HIS GLY SEQRES 9 A 260 SER GLU HIS THR VAL ASP GLY VAL LYS TYR SER ALA GLU SEQRES 10 A 260 LEU HIS VAL ALA HIS TRP ASN SER ALA LYS TYR SER SER SEQRES 11 A 260 LEU ALA GLU ALA ALA SER LYS ALA ASP GLY LEU ALA VAL SEQRES 12 A 260 ILE GLY VAL LEU MET LYS VAL GLY GLU ALA ASN PRO LYS SEQRES 13 A 260 LEU GLN LYS VAL LEU ASP ALA LEU GLN ALA ILE LYS THR SEQRES 14 A 260 LYS GLY LYS ARG ALA PRO PHE THR ASN PHE ASP PRO SER SEQRES 15 A 260 THR LEU LEU PRO SER SER LEU ASP PHE TRP THR TYR PRO SEQRES 16 A 260 GLY SER LEU THR HIS PRO PRO LEU TYR GLU SER VAL THR SEQRES 17 A 260 TRP ILE ILE CYS LYS GLU SER ILE SER VAL SER SER GLU SEQRES 18 A 260 GLN LEU ALA GLN PHE ARG SER LEU LEU SER ASN VAL GLU SEQRES 19 A 260 GLY ASP ASN ALA VAL PRO MET GLN HIS ASN ASN ARG PRO SEQRES 20 A 260 THR GLN PRO LEU LYS GLY ARG THR VAL ARG ALA SER PHE HET ZN A 261 1 HETNAM ZN ZINC ION FORMUL 2 ZN ZN 2+ HELIX 1 A TRP A 16 TYR A 20 1CONTIGUOUS WITH HELIX B 5 HELIX 2 B TYR A 20 GLY A 25 5CONTIGUOUS WITH HELIX A 6 HELIX 3 D SER A 130 LYS A 137 1ALSO DESIGNATED AS 3/10 HELIX 8 HELIX 4 E1 PRO A 155 ASP A 162 1CONTIGUOUS WITH HELIX E2 8 HELIX 5 E2 ASP A 162 LYS A 168 1CONTIGUOUS WITH HELIX E1 7 HELIX 6 F PRO A 181 LEU A 185 5 5 HELIX 7 G SER A 219 LEU A 229 1 11 SHEET 1 S10 LYS A 39 ASP A 41 0 SHEET 2 S10 VAL A 256 SER A 259 1 N ASP A 41 O ALA A 258 SHEET 3 S10 PHE A 191 GLY A 196 -1 N THR A 193 O ARG A 257 SHEET 4 S10 SER A 206 CYS A 212 -1 N TRP A 209 O TYR A 194 SHEET 5 S10 GLY A 140 GLY A 151 -1 N VAL A 143 O THR A 208 SHEET 6 S10 ALA A 116 ASN A 124 -1 N VAL A 120 O ILE A 144 SHEET 7 S10 SER A 87 HIS A 96 -1 N HIS A 94 O HIS A 119 SHEET 8 S10 SER A 65 GLU A 71 -1 N HIS A 67 O HIS A 94 SHEET 9 S10 THR A 55 VAL A 62 -1 N ILE A 60 O HIS A 67 SHEET 10 S10 GLY A 171 PHE A 176 -1 N ALA A 174 O ILE A 59 LINK NE2 HIS A 94 ZN ZN A 261 1555 1555 1.93 LINK NE2 HIS A 96 ZN ZN A 261 1555 1555 1.94 LINK ND1 HIS A 119 ZN ZN A 261 1555 1555 1.90 CISPEP 1 SER A 29 PRO A 30 0 -1.75 CISPEP 2 PRO A 201 PRO A 202 0 2.14 SITE 1 AC1 3 HIS A 94 HIS A 96 HIS A 119 CRYST1 81.500 73.600 37.100 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012270 0.000000 0.000000 -0.02494 SCALE2 0.000000 0.013590 0.000000 -0.33832 SCALE3 0.000000 0.000000 0.026950 0.62129